Form 4: Glaukos Director Executes Stock Option Exercise and Sale
Statement of Changes in Beneficial Ownership
Director Gilbert H. Kliman exercised 5,000 stock options and subsequently sold the shares in a routine transaction.
Summary
- Director Gilbert H. Kliman exercised 5,000 stock options at a strike price of $24.69 per share.
- Following the exercise, the director sold the 5,000 shares at a market price of $135.00 per share.
- The transaction resulted in a net reduction of the director's direct holdings to 35,528 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine exercise and sale of vested equity by a director rather than a strategic shift or signal of company performance.
Positives
- The transaction reflects the exercise of long-held options granted in 2016, demonstrating historical alignment with company growth.
Negatives
- The director reduced their direct equity stake in the company by 5,000 shares.
Risks
- None identified; this is a standard Form 4 disclosure of executive equity movement.
Future Outlook
Not applicable as this is a retrospective disclosure of an insider transaction.
Industry Context
StockSavvy.ai notes that insider selling is common among directors and executives for liquidity or tax planning purposes, particularly when options are nearing their expiration date, as seen here with the June 2026 expiration.
Comparison to Industry Standards
- The transaction is consistent with standard corporate governance practices for public company directors.
- The volume of shares sold is relatively small compared to the total outstanding shares of Glaukos Corporation.
Stakeholder Impact
- Minimal impact on shareholders as the transaction size is limited and represents standard executive compensation realization.
Key Dates
| Date | Description |
|---|---|
| 06/02/2016 | Original grant date of the stock options exercised. |
| 06/02/2017 | Date the stock options became fully vested. |
| 05/11/2026 | Date of the option exercise and subsequent sale of shares. |
| 06/02/2026 | Expiration date of the stock options. |
Keywords
Glaukos, GKOS, Insider Trading, Form 4, Director Transaction, Equity Exercise
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.